disease örnekleri

• These changes are subtle and intermittent at first and become more permanent and obvious as the disease progresses.

• A more rigorous analysis of the epidemiological impact of vaccination for meningococcal disease is essential for proper health economic estimates.

• Thus, even if we were measuring the correct symptoms, we could expect that our purely categorical disease would be hidden within a continuous symptom distribution.

• Secondary hypotheses were that abnormal psychological/ endocrine/immune measures were associated with a poorer predicted disease outcome (as evidenced by tumour pathology).

• Older knowledge, perhaps because it has been relocated to regions that are damaged by the disease process, does not fare as well.

• In the past, authors stressed the greater variability of the disease's prognosis, clinical findings and cell morphology.

• First, several simplifying assumptions surrounding the disease process and treatment were necessary to construct the model.

• Instead, they focused on the dominant urban health discourse surrounding reducing the cases of contagious diseases and improving hygiene.

• The interview included an open disease history, a checklist of signs and symptoms, and a structured questionnaire.

• One factor that has not, to our knowledge, been explicitly examined is the role of specific symptoms and disease intensity on transmission.

• The average annualized number of outpatient visits was substantially higher for each disease state compared with the number of inpatient episodes.

• Some of these compounds have been detrimental to the environment, and all too often the disease organisms being targeted have developed resistance.

• Over the past five years, outstanding progress has been made in the development of therapeutic strategies targeting these diseases.

• The main limitations in treating metastatic disease include poor vector transduction efficiencies and difficulties in targeting remote tumour cells with systemic vector delivery.

• Such risk factors are generally considered non-modifiable at the time of disease onset, but may be targets for preventative strategies in the future.